Association of RAD51, XRCC1, XRCC2, and XRCC3 Polymorphisms with Risk of Breast Cancer
Article in Genetic Testing and Molecular Biomarkers (July 2023)
The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.
Relationship between polymorphisms in homologous recombination repair genes RAD51 G172T、XRCC2 & XRCC3 and risk of breast cancer: A meta-analysis
Article in Frontiers in Oncology (January 2023)
CRISPR/Cas9-induced saturated mutagenesis identifies Rad51 haplotype as a marker of PARP inhibitor sensitivity in breast cancer
Article in Molecular Medicine Reports (June 2022)